25 XP   0   0   10

Atrys Health SL
Buy, Hold or Sell?

Let's analyse Atrys Health SL together

PenkeI guess you are interested in Atrys Health SL. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of Atrys Health SL. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

You can find me behind Let's Analyse Together in the top-right of each section.

Get notifications about Atrys Health SL

I send you an email if I find something interesting about Atrys Health SL.

Quick analysis of Atrys Health SL (30 sec.)










What can you expect buying and holding a share of Atrys Health SL? (30 sec.)

How much money do you get?

How much money do you get?
€0.00
When do you have the money?
1 year
How often do you get paid?
0.0%

What is your share worth?

Current worth
€3.91
Expected worth in 1 year
€1.75
How sure are you?
87.5%

+ What do you gain per year?

Total Gains per Share
€-2.16
Return On Investment
-73.3%

For what price can you sell your share?

Current Price per Share
€2.95
Expected price per share
€2.77 - €3.33
How sure are you?
50%

1. Valuation of Atrys Health SL (5 min.)




Live pricePrice per Share (EOD)

€2.95

Intrinsic Value Per Share

€-2.80 - €-2.63

Total Value Per Share

€1.11 - €1.27

2. Growth of Atrys Health SL (5 min.)




Is Atrys Health SL growing?

Current yearPrevious yearGrowGrow %
How rich?$315.9m$359.7m-$43.7m-13.8%

How much money is Atrys Health SL making?

Current yearPrevious yearGrowGrow %
Making money-$48.5m-$25m-$23.5m-48.5%
Net Profit Margin-22.6%-12.6%--

How much money comes from the company's main activities?

3. Financial Health of Atrys Health SL (5 min.)




4. Comparing to competitors in the Biotechnology industry (5 min.)




  Industry Rankings (Biotechnology)  


Richest
#173 / 1009

Most Revenue
#63 / 1009

Most Profit
#886 / 1009

Most Efficient
#493 / 1009

What can you expect buying and holding a share of Atrys Health SL? (5 min.)

Welcome investor! Atrys Health SL's management wants to use your money to grow the business. In return you get a share of Atrys Health SL.

What can you expect buying and holding a share of Atrys Health SL?

First you should know what it really means to hold a share of Atrys Health SL. And how you can make/lose money.

Speculation

The Price per Share of Atrys Health SL is €2.95. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Atrys Health SL.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Atrys Health SL, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is €3.91. Based on the TTM, the Book Value Change Per Share is €-0.54 per quarter. Based on the YOY, the Book Value Change Per Share is €0.84 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is €0.00 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Atrys Health SL.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 % of Price per Share% of Price per Share% of Price per Share% of Price per Share% of Price per Share
Usd Eps-0.64-21.7%-0.64-21.7%-0.33-11.1%-0.27-9.3%-0.17-5.8%
Usd Book Value Change Per Share-0.58-19.5%-0.58-19.5%0.8930.3%0.7625.7%0.5217.6%
Usd Dividend Per Share0.000.0%0.000.0%0.000.0%0.000.0%0.000.0%
Usd Total Gains Per Share-0.58-19.5%-0.58-19.5%0.8930.3%0.7625.7%0.5217.6%
Usd Price Per Share3.91-3.91-6.61-7.23-5.33-
Price to Earnings Ratio-6.11--6.11--20.23--760.39-1,977.72-
Price-to-Total Gains Ratio-6.79--6.79-7.40-10.33-17.76-
Price to Book Ratio0.94-0.94-1.39-4.72-5.65-
Price-to-Total Gains Ratio-6.79--6.79-7.40-10.33-17.76-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share3.14352
Number of shares318
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.000.00
Usd Book Value Change Per Share-0.580.76
Usd Total Gains Per Share-0.580.76
Gains per Quarter (318 shares)-183.23241.25
Gains per Year (318 shares)-732.92964.98
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
10-733-7430965955
20-1466-1476019301920
30-2199-2209028952885
40-2932-2942038603850
50-3665-3675048254815
60-4398-4408057905780
70-5130-5141067556745
80-5863-5874077207710
90-6596-6607086858675
100-7329-7340096509640

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share0.01.00.00.0%0.03.00.00.0%0.05.00.00.0%3.05.00.037.5%3.05.00.037.5%
Book Value Change Per Share0.01.00.00.0%2.01.00.066.7%4.01.00.080.0%7.01.00.087.5%7.01.00.087.5%
Dividend per Share0.00.01.00.0%0.00.03.00.0%0.00.05.00.0%0.00.08.00.0%0.00.08.00.0%
Total Gains per Share0.01.00.00.0%2.01.00.066.7%4.01.00.080.0%7.01.00.087.5%7.01.00.087.5%

Fundamentals of Atrys Health SL

About Atrys Health SL

Atrys Health, S.A., a biomedical company, provides diagnostic services and medical treatments. The company offers diagnostic services in the fields of pathology, hematology, molecular pathology, and genetics; and diagnostic second opinion, test directory, and clinical trials and R&D services. It uses telemedicine to provide its services in the medical specialties of radiology, cardiology, ophthalmology, and dermatology. The company also provides radiotherapy; and develops therapeutic modalities and diagnostic tools. The company was formerly known as Althia Health, S.L. and changed its name to Atrys Health, S.A. in May 2016. The company was incorporated in 2007 and is headquartered in Madrid, Spain.

Fundamental data was last updated by Penke on 2024-04-09 21:27:05.

Financial Health

Profitability Details
 Compared to previous yearCompared to industry
The company is making a huge loss.
Using its assets, the company is very inefficient in making profit.
Using its investors money, the company is very inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is operating less efficient.
The company is less efficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is just not able to pay all its short-term debts.
The company is just not able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is able to pay all its debts by selling its assets.
The company is able to pay all its debts with equity.

Valuation

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is cheap.
Based on the earnings, the company is expensive.
Based on how much money comes from the company's main activities, the company is expensive.

1.1. Profitability of Atrys Health SL.

1.1. Profitability
1.1.1. Net Profit Margin

Measures how much net profit Atrys Health SL earns for each €1 of revenue.

  • Above 10% is considered healthy but always compare Atrys Health SL to the Biotechnology industry mean.
  • A Net Profit Margin of -22.6% means that €-0.23 for each €1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Atrys Health SL:

  • The MRQ is -22.6%. The company is making a huge loss. -2
  • The TTM is -22.6%. The company is making a huge loss. -2
Trends
Current periodCompared to+/- 
MRQ-22.6%TTM-22.6%0.0%
TTM-22.6%YOY-12.6%-10.1%
TTM-22.6%5Y-12.3%-10.3%
5Y-12.3%10Y-7.3%-5.0%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-22.6%-200.1%+177.5%
TTM-22.6%-216.8%+194.2%
YOY-12.6%-288.3%+275.7%
5Y-12.3%-449.1%+436.8%
10Y-7.3%-605.5%+598.2%
1.1.2. Return on Assets

Shows how efficient Atrys Health SL is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Atrys Health SL to the Biotechnology industry mean.
  • -7.2% Return on Assets means that Atrys Health SL generated €-0.07 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Atrys Health SL:

  • The MRQ is -7.2%. Using its assets, the company is very inefficient in making profit. -2
  • The TTM is -7.2%. Using its assets, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-7.2%TTM-7.2%0.0%
TTM-7.2%YOY-3.3%-3.9%
TTM-7.2%5Y-3.2%-4.1%
5Y-3.2%10Y-1.9%-1.3%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-7.2%-13.3%+6.1%
TTM-7.2%-12.8%+5.6%
YOY-3.3%-11.7%+8.4%
5Y-3.2%-13.9%+10.7%
10Y-1.9%-15.7%+13.8%
1.1.3. Return on Equity

Shows how efficient Atrys Health SL is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Atrys Health SL to the Biotechnology industry mean.
  • -15.7% Return on Equity means Atrys Health SL generated €-0.16 for each €1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Atrys Health SL:

  • The MRQ is -15.7%. Using its investors money, the company is very inefficient in making profit. -2
  • The TTM is -15.7%. Using its investors money, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-15.7%TTM-15.7%0.0%
TTM-15.7%YOY-7.0%-8.8%
TTM-15.7%5Y-6.8%-8.9%
5Y-6.8%10Y-4.1%-2.7%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-15.7%-16.9%+1.2%
TTM-15.7%-16.1%+0.4%
YOY-7.0%-15.1%+8.1%
5Y-6.8%-19.3%+12.5%
10Y-4.1%-20.2%+16.1%

1.2. Operating Efficiency of Atrys Health SL.

1.2. Operating Efficiency
1.2.1. Operating Margin

Measures how efficient Atrys Health SL is operating .

  • Measures how much profit Atrys Health SL makes for each €1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Atrys Health SL to the Biotechnology industry mean.
  • An Operating Margin of 1.9% means the company generated €0.02  for each €1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Atrys Health SL:

  • The MRQ is 1.9%. The company is operating less efficient.
  • The TTM is 1.9%. The company is operating less efficient.
Trends
Current periodCompared to+/- 
MRQ1.9%TTM1.9%0.0%
TTM1.9%YOY4.5%-2.6%
TTM1.9%5Y1.5%+0.4%
5Y1.5%10Y4.3%-2.8%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ1.9%-296.2%+298.1%
TTM1.9%-232.5%+234.4%
YOY4.5%-298.2%+302.7%
5Y1.5%-492.1%+493.6%
10Y4.3%-632.4%+636.7%
1.2.2. Operating Ratio

Measures how efficient Atrys Health SL is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Biotechnology industry mean).
  • An Operation Ratio of 0.98 means that the operating costs are €0.98 for each €1 in net sales.

Let's take a look of the Operating Ratio trends of Atrys Health SL:

  • The MRQ is 0.981. The company is less efficient in keeping operating costs low.
  • The TTM is 0.981. The company is less efficient in keeping operating costs low.
Trends
Current periodCompared to+/- 
MRQ0.981TTM0.9810.000
TTM0.981YOY1.002-0.021
TTM0.9815Y0.990-0.008
5Y0.99010Y0.973+0.016
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.9813.231-2.250
TTM0.9813.310-2.329
YOY1.0023.890-2.888
5Y0.9905.739-4.749
10Y0.9737.876-6.903

1.3. Liquidity of Atrys Health SL.

1.3. Liquidity
1.3.1. Current Ratio

Measures if Atrys Health SL is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Biotechnology industry mean).
  • A Current Ratio of 0.97 means the company has €0.97 in assets for each €1 in short-term debts.

Let's take a look of the Current Ratio trends of Atrys Health SL:

  • The MRQ is 0.973. The company is just not able to pay all its short-term debts. -1
  • The TTM is 0.973. The company is just not able to pay all its short-term debts. -1
Trends
Current periodCompared to+/- 
MRQ0.973TTM0.9730.000
TTM0.973YOY1.025-0.052
TTM0.9735Y1.403-0.430
5Y1.40310Y1.768-0.365
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.9733.890-2.917
TTM0.9734.173-3.200
YOY1.0255.344-4.319
5Y1.4036.126-4.723
10Y1.7686.448-4.680
1.3.2. Quick Ratio

Measures if Atrys Health SL is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Atrys Health SL to the Biotechnology industry mean.
  • A Quick Ratio of 0.89 means the company can pay off €0.89 for each €1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Atrys Health SL:

  • The MRQ is 0.895. The company is just not able to pay all its short-term debts with the most liquid assets. -1
  • The TTM is 0.895. The company is just not able to pay all its short-term debts with the most liquid assets. -1
Trends
Current periodCompared to+/- 
MRQ0.895TTM0.8950.000
TTM0.895YOY0.976-0.081
TTM0.8955Y1.378-0.483
5Y1.37810Y1.739-0.361
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.8953.514-2.619
TTM0.8953.998-3.103
YOY0.9765.380-4.404
5Y1.3786.105-4.727
10Y1.7396.404-4.665

1.4. Solvency of Atrys Health SL.

1.3. Liquidity
1.4.1. Debt to Asset Ratio

Measures how much % of Atrys Health SL assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Atrys Health SL to Biotechnology industry mean.
  • A Debt to Asset Ratio of 0.53 means that Atrys Health SL assets are financed with 52.9% credit (debt) and the remaining percentage (100% - 52.9%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Atrys Health SL:

  • The MRQ is 0.529. The company is able to pay all its debts by selling its assets. +1
  • The TTM is 0.529. The company is able to pay all its debts by selling its assets. +1
Trends
Current periodCompared to+/- 
MRQ0.529TTM0.5290.000
TTM0.529YOY0.521+0.007
TTM0.5295Y0.537-0.008
5Y0.53710Y0.518+0.019
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.5290.339+0.190
TTM0.5290.336+0.193
YOY0.5210.271+0.250
5Y0.5370.366+0.171
10Y0.5180.389+0.129
1.4.2. Debt to Equity Ratio

Measures if Atrys Health SL is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Atrys Health SL to the Biotechnology industry mean.
  • A Debt to Equity ratio of 114.7% means that company has €1.15 debt for each €1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Atrys Health SL:

  • The MRQ is 1.147. The company is able to pay all its debts with equity. +1
  • The TTM is 1.147. The company is able to pay all its debts with equity. +1
Trends
Current periodCompared to+/- 
MRQ1.147TTM1.1470.000
TTM1.147YOY1.089+0.058
TTM1.1475Y1.167-0.021
5Y1.16710Y1.092+0.075
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ1.1470.388+0.759
TTM1.1470.402+0.745
YOY1.0890.335+0.754
5Y1.1670.426+0.741
10Y1.0920.461+0.631

2. Market Valuation of Atrys Health SL

2.1. Earnings Per Share
2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every €1 in earnings Atrys Health SL generates.

  • Above 15 is considered overpriced but always compare Atrys Health SL to the Biotechnology industry mean.
  • A PE ratio of -6.11 means the investor is paying €-6.11 for every €1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Atrys Health SL:

  • The EOD is -4.910. Based on the earnings, the company is expensive. -2
  • The MRQ is -6.108. Based on the earnings, the company is expensive. -2
  • The TTM is -6.108. Based on the earnings, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-4.910MRQ-6.108+1.198
MRQ-6.108TTM-6.1080.000
TTM-6.108YOY-20.226+14.118
TTM-6.1085Y-760.388+754.280
5Y-760.38810Y1,977.720-2,738.108
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD-4.910-2.264-2.646
MRQ-6.108-2.629-3.479
TTM-6.108-2.680-3.428
YOY-20.226-4.145-16.081
5Y-760.388-6.257-754.131
10Y1,977.720-6.254+1,983.974
2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Atrys Health SL:

  • The EOD is -15.718. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The MRQ is -19.554. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The TTM is -19.554. Based on how much money comes from the company's main activities, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-15.718MRQ-19.554+3.836
MRQ-19.554TTM-19.5540.000
TTM-19.554YOY-15.377-4.178
TTM-19.5545Y-87.363+67.809
5Y-87.36310Y-84.629-2.734
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD-15.718-2.973-12.745
MRQ-19.554-3.333-16.221
TTM-19.554-3.553-16.001
YOY-15.377-5.605-9.772
5Y-87.363-8.376-78.987
10Y-84.629-8.865-75.764
2. Book Value per Share
2.3. Price to Book Ratio

Measures if the stock price of Atrys Health SL is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Biotechnology industry mean).
  • A PB ratio of 0.94 means the investor is paying €0.94 for each €1 in book value.

Let's take a look of the Price to Book Ratio trends of Atrys Health SL:

  • The EOD is 0.755. Based on the equity, the company is cheap. +2
  • The MRQ is 0.939. Based on the equity, the company is cheap. +2
  • The TTM is 0.939. Based on the equity, the company is cheap. +2
Trends
Current periodCompared to+/- 
EOD0.755MRQ0.939-0.184
MRQ0.939TTM0.9390.000
TTM0.939YOY1.394-0.455
TTM0.9395Y4.721-3.782
5Y4.72110Y5.646-0.925
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD0.7551.896-1.141
MRQ0.9392.115-1.176
TTM0.9392.093-1.154
YOY1.3942.884-1.490
5Y4.7213.542+1.179
10Y5.6463.916+1.730
2. Total Gains per Share

3. Summary

3.1. Key Performance Indicators

The key performance indicators of Atrys Health SL compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share---0.541-0.5410%0.838-165%0.712-176%0.489-211%
Book Value Per Share--3.9083.9080%4.449-12%2.697+45%1.791+118%
Current Ratio--0.9730.9730%1.025-5%1.403-31%1.768-45%
Debt To Asset Ratio--0.5290.5290%0.521+1%0.537-2%0.518+2%
Debt To Equity Ratio--1.1471.1470%1.089+5%1.167-2%1.092+5%
Dividend Per Share----0%-0%-0%-0%
Eps---0.601-0.6010%-0.307-49%-0.258-57%-0.160-73%
Free Cash Flow Per Share---0.188-0.1880%-0.403+115%-0.156-17%-0.108-42%
Free Cash Flow To Equity Per Share---0.080-0.0800%0.846-109%0.367-122%0.256-131%
Gross Profit Margin--1.0001.0000%1.034-3%1.034-3%1.021-2%
Intrinsic Value_10Y_max---2.634--------
Intrinsic Value_10Y_min---2.802--------
Intrinsic Value_1Y_max---0.180--------
Intrinsic Value_1Y_min---0.233--------
Intrinsic Value_3Y_max---0.604--------
Intrinsic Value_3Y_min---0.746--------
Intrinsic Value_5Y_max---1.105--------
Intrinsic Value_5Y_min---1.305--------
Market Cap223840690.000-24%278472994.000278472994.0000%470444840.000-41%514757708.800-46%379478259.930-27%
Net Profit Margin---0.226-0.2260%-0.126-45%-0.123-46%-0.073-68%
Operating Margin--0.0190.0190%0.045-58%0.015+26%0.043-56%
Operating Ratio--0.9810.9810%1.002-2%0.990-1%0.973+1%
Pb Ratio0.755-24%0.9390.9390%1.394-33%4.721-80%5.646-83%
Pe Ratio-4.910+20%-6.108-6.1080%-20.226+231%-760.388+12349%1977.720-100%
Price Per Share2.950-24%3.6703.6700%6.200-41%6.784-46%5.001-27%
Price To Free Cash Flow Ratio-15.718+20%-19.554-19.5540%-15.377-21%-87.363+347%-84.629+333%
Price To Total Gains Ratio-5.456+20%-6.787-6.7870%7.398-192%10.332-166%17.756-138%
Quick Ratio--0.8950.8950%0.976-8%1.378-35%1.739-49%
Return On Assets---0.072-0.0720%-0.033-54%-0.032-56%-0.019-73%
Return On Equity---0.157-0.1570%-0.070-56%-0.068-57%-0.041-74%
Total Gains Per Share---0.541-0.5410%0.838-165%0.712-176%0.489-211%
Usd Book Value--315997286.400315997286.4000%359717788.800-12%218102284.621+45%144839276.274+118%
Usd Book Value Change Per Share---0.576-0.5760%0.893-165%0.759-176%0.521-211%
Usd Book Value Per Share--4.1654.1650%4.741-12%2.874+45%1.909+118%
Usd Dividend Per Share----0%-0%-0%-0%
Usd Eps---0.640-0.6400%-0.327-49%-0.275-57%-0.171-73%
Usd Free Cash Flow---15175209.600-15175209.6000%-32602032.000+115%-12598284.742-17%-8768719.041-42%
Usd Free Cash Flow Per Share---0.200-0.2000%-0.430+115%-0.166-17%-0.116-42%
Usd Free Cash Flow To Equity Per Share---0.085-0.0850%0.901-109%0.391-122%0.273-131%
Usd Market Cap238524639.264-24%296740822.406296740822.4060%501306021.504-41%548525814.497-46%404372033.781-27%
Usd Price Per Share3.144-24%3.9113.9110%6.607-41%7.229-46%5.329-27%
Usd Profit---48580704.000-48580704.0000%-25007500.800-49%-20113183.225-59%-12547804.487-74%
Usd Revenue--214791926.400214791926.4000%199260806.400+8%118454249.578+81%76416856.067+181%
Usd Total Gains Per Share---0.576-0.5760%0.893-165%0.759-176%0.521-211%
 EOD+3 -5MRQTTM+0 -0YOY+8 -265Y+10 -2410Y+7 -27

3.2. Fundamental Score

Let's check the fundamental score of Atrys Health SL based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-15-4.910
Price to Book Ratio (EOD)Between0-10.755
Net Profit Margin (MRQ)Greater than0-0.226
Operating Margin (MRQ)Greater than00.019
Quick Ratio (MRQ)Greater than10.895
Current Ratio (MRQ)Greater than10.973
Debt to Asset Ratio (MRQ)Less than10.529
Debt to Equity Ratio (MRQ)Less than11.147
Return on Equity (MRQ)Greater than0.15-0.157
Return on Assets (MRQ)Greater than0.05-0.072
Total3/10 (30.0%)

3.3. Technical Score

Let's check the technical score of Atrys Health SL based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5036.085
Ma 20Greater thanMa 503.037
Ma 50Greater thanMa 1003.066
Ma 100Greater thanMa 2003.358
OpenGreater thanClose2.940
Total0/5 (0.0%)



Reversals in quarterly reports

I have detected a reversal (positive to negative, negative to positive) in the following values of the quarterly reports.

 2019-12-312020-12-312021-12-312022-12-312023-12-31
Net Working Capital  8,2077,64715,85415,75031,604-29,0622,542-5,314-2,772



Latest Balance Sheet

Balance Sheet of 2023-12-31. Currency in EUR. All numbers in thousands.

Summary
Total Assets629,001
Total Liabilities332,457
Total Stockholder Equity289,872
 As reported
Total Liabilities 332,457
Total Stockholder Equity+ 289,872
Total Assets = 629,001

Assets

Total Assets629,001
Total Current Assets100,870
Long-term Assets528,131
Total Current Assets
Cash And Cash Equivalents 41,829
Short-term Investments 348
Net Receivables 50,582
Inventory 1,677
Other Current Assets 6,782
Total Current Assets  (as reported)100,870
Total Current Assets  (calculated)101,218
+/- 348
Long-term Assets
Property Plant Equipment 62,479
Goodwill 275,740
Intangible Assets 174,745
Long-term Assets  (as reported)528,131
Long-term Assets  (calculated)512,964
+/- 15,167

Liabilities & Shareholders' Equity

Total Current Liabilities103,642
Long-term Liabilities228,815
Total Stockholder Equity289,872
Total Current Liabilities
Short-term Debt 64,311
Short Long Term Debt 57,869
Accounts payable 19,136
Other Current Liabilities 20,009
Total Current Liabilities  (as reported)103,642
Total Current Liabilities  (calculated)161,325
+/- 57,683
Long-term Liabilities
Long term Debt 162,726
Capital Lease Obligations 40,707
Long-term Liabilities  (as reported)228,815
Long-term Liabilities  (calculated)203,433
+/- 25,382
Total Stockholder Equity
Common Stock760
Accumulated Other Comprehensive Income -130,648
Other Stockholders Equity 419,760
Total Stockholder Equity (as reported)289,872
Total Stockholder Equity (calculated)289,872
+/-0
Other
Capital Stock760
Cash and Short Term Investments 41,829
Common Stock Shares Outstanding 75,811
Current Deferred Revenue186
Liabilities and Stockholders Equity 629,001
Net Debt 212,171
Net Invested Capital 510,467
Net Working Capital -2,772
Property Plant and Equipment Gross 142,895
Short Long Term Debt Total 254,000



Balance Sheet

Currency in EUR. All numbers in thousands.

 Trend2023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-312015-12-312014-12-312013-12-312012-12-31
> Total Assets 
18,294
18,871
19,530
26,095
30,569
40,197
53,693
88,043
175,776
565,632
705,281
629,001
629,001705,281565,632175,77688,04353,69340,19730,56926,09519,53018,87118,294
   > Total Current Assets 
4,764
3,688
2,978
3,481
7,006
13,400
15,500
18,026
37,264
103,106
103,105
100,870
100,870103,105103,10637,26418,02615,50013,4007,0063,4812,9783,6884,764
       Cash And Cash Equivalents 
454
691
448
915
2,850
9,268
9,763
8,329
17,476
35,126
34,295
41,829
41,82934,29535,12617,4768,3299,7639,2682,850915448691454
       Short-term Investments 
0
0
0
0
179
142
151
439
129
5,441
1,549
348
3481,5495,4411294391511421790000
       Net Receivables 
0
0
0
0
3,795
3,779
4,939
9,131
19,005
56,636
60,767
50,582
50,58260,76756,63619,0059,1314,9393,7793,7950000
       Other Current Assets 
4,310
2,997
2,530
2,565
3,796
3,782
5,326
226
0
3,978
6,830
6,782
6,7826,8303,97802265,3263,7823,7962,5652,5302,9974,310
   > Long-term Assets 
13,530
15,184
16,552
22,614
23,564
26,797
38,193
70,017
138,512
462,526
602,176
528,131
528,131602,176462,526138,51270,01738,19326,79723,56422,61416,55215,18413,530
       Property Plant Equipment 
2,255
930
739
3,170
2,755
2,571
2,648
5,738
9,843
62,538
69,331
62,479
62,47969,33162,5389,8435,7382,6482,5712,7553,1707399302,255
       Goodwill 
0
0
0
0
1,744
1,550
10,095
35,460
95,051
235,836
306,212
275,740
275,740306,212235,83695,05135,46010,0951,5501,7440000
       Intangible Assets 
7,387
9,565
10,898
0
13,649
15,177
17,009
19,542
26,482
151,132
212,690
174,745
174,745212,690151,13226,48219,54217,00915,17713,649010,8989,5657,387
       Long-term Assets Other 
428
417
420
15,212
179
1,881
2,807
4,046
988
8,378
4,130
177,274
177,2744,1308,3789884,0462,8071,88117915,212420417428
> Total Liabilities 
0
0
0
0
16,306
16,899
27,250
48,089
100,448
291,653
367,708
332,457
332,457367,708291,653100,44848,08927,25016,89916,3060000
   > Total Current Liabilities 
1,006
888
602
3,169
4,369
4,966
5,480
9,819
21,410
71,502
100,563
103,642
103,642100,56371,50221,4109,8195,4804,9664,3693,1696028881,006
       Short-term Debt 
230
342
110
1,832
3,242
1,152
3,024
4,486
11,822
25,586
48,255
64,311
64,31148,25525,58611,8224,4863,0241,1523,2421,832110342230
       Short Long Term Debt 
0
0
0
0
0
1,143
2,904
3,787
11,082
15,518
23,364
57,869
57,86923,36415,51811,0823,7872,9041,14300000
       Accounts payable 
326
112
239
924
626
970
798
2,000
4,255
10,365
15,686
19,136
19,13615,68610,3654,2552,000798970626924239112326
       Other Current Liabilities 
450
434
253
412
501
2,844
1,229
268
310
294
294
20,009
20,0092942943102681,2292,844501412253434450
   > Long-term Liabilities 
11,230
11,366
12,007
12,639
11,937
11,933
21,771
38,270
79,038
220,151
267,145
228,815
228,815267,145220,15179,03838,27021,77111,93311,93712,63912,00711,36611,230
       Long term Debt Total 
0
0
0
0
0
0
6,420
5,411
10,077
0
0
0
00010,0775,4116,420000000
       Other Liabilities 
0
0
0
0
1,647
6,539
6,767
8,081
28,609
41,283
56,730
0
056,73041,28328,6098,0816,7676,5391,6470000
       Deferred Long Term Liability 
0
0
0
0
12,933
14,193
15,447
16,284
22,622
23,521
24,835
0
024,83523,52122,62216,28415,44714,19312,9330000
> Total Stockholder Equity
6,058
6,618
6,921
10,287
14,263
23,298
26,443
39,954
75,328
274,030
337,630
289,872
289,872337,630274,03075,32839,95426,44323,29814,26310,2876,9216,6186,058
   Common Stock
4
4
4
66
112
176
216
256
347
614
760
760
76076061434725621617611266444
   Retained Earnings 
682
337
320
1,295
63
97
12
-105
-2,015
-23,255
-23,259
-45,590
-45,590-23,259-23,255-2,015-1051297631,295320337682
   Capital Surplus 
0
0
0
0
0
0
24,959
38,426
78,079
0
0
0
00078,07938,42624,959000000
   Treasury Stock000000000000
   Other Stockholders Equity 
5,372
6,278
6,597
8,927
14,089
23,025
26,215
38,383
76,996
296,671
22,499
419,760
419,76022,499296,67176,99638,38326,21523,02514,0898,9276,5976,2785,372



Balance Sheet

Currency in EUR. All numbers in thousands.




Cash Flow

Currency in EUR. All numbers in thousands.




Income Statement

Currency in EUR. All numbers in thousands.


Latest Income Statement (annual, 2023-12-31)

Gross Profit (+$)
totalRevenue201,569
Cost of Revenue-170,027
Gross Profit31,54231,542
 
Operating Income (+$)
Gross Profit31,542
Operating Expense-27,748
Operating Income3,7943,794
 
Operating Expense (+$)
Research Development0
Selling General Administrative6,874
Selling And Marketing Expenses0
Operating Expense27,7486,874
 
Net Interest Income (+$)
Interest Income627
Interest Expense-33,047
Other Finance Cost-0
Net Interest Income-32,420
 
Pretax Income (+$)
Operating Income3,794
Net Interest Income-32,420
Other Non-Operating Income Expenses0
Income Before Tax (EBT)-30,80638,394
EBIT - interestExpense = -29,253
-45,641
-12,543
Interest Expense33,047
Earnings Before Interest and Taxes (EBIT)3,7942,241
Earnings Before Interest and Taxes (EBITDA)33,467
 
After tax Income (+$)
Income Before Tax-30,806
Tax Provision--2,941
Net Income From Continuing Ops-30,755-27,865
Net Income-45,590
Net Income Applicable To Common Shares0
 
Non-recurring Events
Discontinued Operations0
Extraordinary Items0
Effect of Accounting Charges0
Other Items0
Non Recurring0
Other Operating Expenses197,775
Total Other Income/Expenses Net-34,60032,420
 

Technical Analysis of Atrys Health SL
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Atrys Health SL. The general trend of Atrys Health SL is BEARISH with 100.0% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Atrys Health SL's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (-100.0%) Bearish trend (100.0%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of Atrys Health SL.

The long score for the Support & Resistance is 0/1.
The longshort score for the Support & Resistance is 0/(-1 +1).

  • Between support/resistance: The price is trading between support and resistance lines.

The bullish price targets are: 3.04 < 3.3 < 3.33.

The bearish price targets are: 2.77.

Tweet this
Atrys Health SL Daily Support & Resistance Chart

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of Atrys Health SL. The current mas is .

The long score for the Moving Averages is 0/14.
The longshort score for the Moving Averages is -14/(-14 +14).

  • MA 20 trending down: The MA 20 is trending down. -1
  • Close < MA 20: The price is below the MA 20. -1
  • MA 20 < MA 50: The MA 20 is lower than the MA 50. -1
  • MA 20 < MA 100: The MA 20 is lower than the MA 100. -1
  • MA 20 < MA 200: The MA 20 is lower than the MA 200. -1
  • MA 50 trending down: The MA 50 is trending down. -1
  • Close < MA 50: The price is below the MA 50. -1
  • MA 50 < MA 100: The MA 50 is lower than the MA 100. -1
  • MA 50 < MA 200: The MA 50 is lower than the MA 200. -1
  • MA 100 trending down: The MA 100 is trending down. -1
  • Close < MA 100: The price is below the MA 100. -1
  • MA 100 < MA 200: The MA 100 is lower than the MA 200. -1
  • MA 200 trending down: The MA 200 is trending down. -1
  • Close < MA 200: The price is below the MA 200. -1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

Atrys Health SL Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of Atrys Health SL. The current macd is -0.04670825.

The long score for the Moving Average Convergence/Divergence (MACD) is 0/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is -4/(-4 +4).

  • MACD line < signal line: The MACD line is below the signal line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the Atrys Health SL price going down in the near term. -2
  • MACD < 0: The MACD is below the zero line (centerline), it indicates a bearish signal for Atrys Health SL. This means that the short-term moving average is lower than the long-term moving average, signaling negative momentum and suggesting a higher likelihood of the Atrys Health SL price continuing to fall in the near future. It indicates that sellers are gaining control, and there is negativism in the market, leading to potential price decreases. -1
  • Trending down: The MACD line is trending down. This indicates that the short-term moving average is falling faster than the long-term moving average, suggesting negative momentum in the market. This signals that sellers are becoming more active and insecure, leading to potential price decreases as traders anticipate further losses and are willing to sell at lower prices. -1
Atrys Health SL Daily Moving Average Convergence/Divergence (MACD) ChartAtrys Health SL Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of Atrys Health SL. The current adx is 18.17.

The long score for the Directional Movement Index (DMI) is 0/7.
The longshort score for the Directional Movement Index (DMI) is -2/(-7 +7).

  • PLUS_ID < MINUS_DI: The +DI line is below the -DI line. This indicates a bearish signal in the market, as the negative directional movement is currently stronger than the positive directional movement, showing that sellers have the upper hand. Market psychology suggests that traders are pessimistic, expecting further price decreases, and are more willing to sell Atrys Health SL shares, leading to potential downward momentum in its price. -1
  • PLUS_ID < MINUS_DI && ADX < 25 && ADX trending up: The ADX is below 25 and indicates a weak or no trend. However, the ADX is rising and a new bearish trend could be forming. -1
Atrys Health SL Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of Atrys Health SL. The current sar is 3.16201997.

The long score for the Parabolic SAR is 0/1.
The longshort score for the Parabolic SAR is -1/(-1 +1).

  • Close < SAR: The price is below the SAR. It's generally considered a bearish signal. -1
Atrys Health SL Daily Parabolic SAR Chart

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of Atrys Health SL. The current rsi is 36.09. The current phase is Continuation in bear market.

The long score for the Relative Strength Index (RSI) is 1/13.
The longshort score for the Relative Strength Index (RSI) is -2/(-13 +13).

  • Continuation in bear market: Downtrend continues after a consolidation or pullback. Hold or add to short positions.
  • Trending up: The RSI is trending up. +1
Atrys Health SL Daily Relative Strength Index (RSI) ChartAtrys Health SL Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of Atrys Health SL. The current phase is Continuation in bear market.

The long score for the Stochastic Oscillator is 3/6.
The longshort score for the Stochastic Oscillator is 2/(-6 +6).

  • STOCH < 50: The STOCH %K is below 50. There are more sellers than buyers. -1
  • STOCH %K line > STOCH %D line: The STOCH %K line is above the STOCH %D line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the Atrys Health SL price going up in the near term. +2
  • Trending up: The STOCH %K is trending up. +1
Atrys Health SL Daily Stochastic Oscillator ChartAtrys Health SL Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of Atrys Health SL. The current cci is -93.28487366.

Atrys Health SL Daily Commodity Channel Index (CCI) ChartAtrys Health SL Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of Atrys Health SL. The current cmo is -32.3997204.

The long score for the Chande Momentum Oscillator (CMO) is 0/1.
The longshort score for the Chande Momentum Oscillator (CMO) is -1/(-1 +1).

  • CMO < 0: The CMO is below 0, the momentum of the price is negative, indicating a potential downtrend in the price. -1
Atrys Health SL Daily Chande Momentum Oscillator (CMO) ChartAtrys Health SL Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of Atrys Health SL. The current willr is -78.26086957.

The long score for the Williams %R is 0/1.
The longshort score for the Williams %R is 0/(-1 +1).

  • WILLR between -80 and -20: The Williams %R is between -80 and -20. This indicates that Atrys Health SL is trading in a neutral price range, neither oversold nor overbought, suggesting a balanced market condition without any extreme price signals.
Atrys Health SL Daily Williams %R ChartAtrys Health SL Daily Williams %R Chart

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of Atrys Health SL.

Atrys Health SL Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of Atrys Health SL. The current atr is 0.07503538.

Atrys Health SL Daily Average True Range (ATR) ChartAtrys Health SL Daily Average True Range (ATR) Chart

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of Atrys Health SL. The current obv is -2,434,769.

Atrys Health SL Daily On-Balance Volume (OBV) ChartAtrys Health SL Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of Atrys Health SL. The current mfi is 25.06.

The long score for the Money Flow Index (MFI) is 0/2.
The longshort score for the Money Flow Index (MFI) is -1/(-2 +2).

  • MFI < 50: -1
Atrys Health SL Daily Money Flow Index (MFI) ChartAtrys Health SL Daily Money Flow Index (MFI) Chart

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for Atrys Health SL.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2023-11-30CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2023-12-04STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-05CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2023-12-07STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2023-12-08STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2023-12-12STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-14CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2023-12-15STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2023-12-18STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2023-12-19MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2023-12-21STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-27CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2023-12-28STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2023-12-29CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-01-02STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-01-03CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-01-04CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-01-05MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2024-01-08STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-09DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2024-01-11MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-01-12DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-01-15DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-16CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-01-17DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-01-18DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
2024-01-19DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-22STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-01-23STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-25DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
2024-01-26SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-01-29DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
2024-01-30SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-01-31STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-02STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-02-05RSI LONG ENTRY SHORT CLOSE30 crossover to upside
STOCH SHORT EXITThe %K line crosses above the %D line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-02-06STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-02-07RSI LONG ENTRY SHORT CLOSE30 crossover to upside
2024-02-08STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-02-09STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-15STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-20CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-02-22MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-02-23MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
RSI LONG ENTRY SHORT CLOSE30 crossover to upside
2024-03-01WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-03-05CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-03-06DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH LONG EXITThe %K line crosses below the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-03-08STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2024-03-11STOCH LONG EXITThe %K line crosses below the %D line.
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-03-12CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-03-13MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-03-14DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2024-03-15DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
2024-03-18WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-03-19DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-03-20DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
2024-03-21STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-03-22SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-03-27STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-28CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-04-03STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-04-05STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-04-09STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-10STOCH LONG EXITThe %K line crosses below the %D line.
2024-04-11SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-04-12MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-04-15STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-17STOCH LONG EXITThe %K line crosses below the %D line.
2024-04-18STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-19STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-04-23STOCH SHORT EXITThe %K line crosses above the %D line.

6.3. Candlestick Patterns

Atrys Health SL Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of Atrys Health SL based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5036.085
Ma 20Greater thanMa 503.037
Ma 50Greater thanMa 1003.066
Ma 100Greater thanMa 2003.358
OpenGreater thanClose2.940
Total0/5 (0.0%)
Penke

Good job! You gained 25 XP and 0   0   10 . What's next:

  • Share my analysis of Atrys Health SL with someone you think should read this too:
  • Are you bullish or bearish on Atrys Health SL? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Atrys Health SL? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about Atrys Health SL

I send you an email if I find something interesting about Atrys Health SL.


Comments

How you think about this?

Leave a comment

Stay informed about Atrys Health SL.

Receive notifications about Atrys Health SL in your mailbox!